|Year : 2018 | Volume
| Issue : 12 | Page : 1084-1090
An updated meta-analysis for association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer
Wen-Zhou Liu, Yu Sun, Xu Feng, Xiao-Han Bi, Tao Liu, Hua-Fu Zhou
Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
|Date of Web Publication||11-Dec-2018|
Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021
Source of Support: None, Conflict of Interest: None
Aim of Study: The conclusions on the association between glutathione S-transferase P1 (GSTP1) gene polymorphism and lung cancer risk are still debated. This meta-analysis was performed to update the association between GSTP1 and the risk of lung cancer.
Materials and Methods: The association investigations were identified from PubMed and Cochrane Library, and eligible studies were included and synthesized using meta-analysis method.
Results: Fifty reports were included into this meta-analysis for the association of GSTP1 A/G gene polymorphism and lung cancer susceptibility. The association between GSTPI G allele/GG genotype and lung cancer risk was found in this meta-analysis (G allele: odds ratio [OR] = 1.08, 95% confidence interval [CI]: 1.02–1.14, P = 0.006; GG genotype: OR = 1.09, 95% CI: 1.00–1.18, P = 0.04). However, the AA genotype was not associated with the susceptibility of lung cancer.
Conclusion: GSTP1 G allele/GG genotype is associated with the lung cancer susceptibility.
Keywords: A/G gene polymorphism, glutathione S-transferase P1, lung cancer, updated meta-analysis
|How to cite this article:|
Liu WZ, Sun Y, Feng X, Bi XH, Liu T, Zhou HF. An updated meta-analysis for association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer. J Can Res Ther 2018;14, Suppl S5:1084-90
|How to cite this URL:|
Liu WZ, Sun Y, Feng X, Bi XH, Liu T, Zhou HF. An updated meta-analysis for association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer. J Can Res Ther [serial online] 2018 [cited 2020 Feb 25];14:1084-90. Available from: http://www.cancerjournal.net/text.asp?2018/14/12/1084/199455
| > Introduction|| |
Lung cancer is the leading cause of cancer-related death worldwide. For early stages of the disease, lung resection surgery remains the best treatment with curative intent, but significant morbidity is associated, especially among patients with poor pulmonary function and cardiorespiratory fitness. The dismal lethality of lung cancer is due to late stage at diagnosis, and the early diagnosis and incorporation of targeted therapies have modestly improved clinical outcomes. Developing an indicator for the early diagnosis of lung cancer is urgently needed.
The current evidence indicate that glutathione S-transferases (GSTs) can take part in the pathogenesis of cancers. The human GSTP1 A/G gene polymorphism is polymorphic with an A to G transition in exon 5 causing a replacement 105 Ile to Val in the GSTP1 protein. In our previous meta-analysis, we found that GSTP1 G allele was associated with the lung cancer susceptibility. This meta-analysis was performed to update the results in our previous meta-analysis, by including more studies.
| > Materials and Methods|| |
Search strategy for the relationship between glutathione S-transferase P1 gene polymorphism and the risk of lung cancer
The relevant studies were searched from the electronic databases of PubMed and Cochrane Library on May 1, 2016. The retrieval strategy of “(glutathione S-transferase P1 OR GSTP1) AND (polymorphism OR polymorphisms OR genotype OR genotypes OR allele OR alleles) AND (lung cancer OR lung carcinoma OR pulmonary carcinoma)” was entered into these databases. The additional reports were identified through references cited in recruited articles.
Inclusion and exclusion criteria
- The outcome had to be lung cancer
- There had to be at least two comparison groups (lung cancer group vs control group)
- The investigation should provide the data of GSTP1 A/G genotype distribution.
- Review articles and editorials
- Case reports
- Preliminary result not on GSTP1 gene polymorphism or outcome
- Investigating the role GSTP1 gene expression to disease
- If multiple publications for the same data from the same study group occurred, we only recruited the later paper into our final analysis.
The following information from each eligible study was extracted independently by two investigators:First author's surname, year of publication, ethnicity, control source of the control group and the number of cases and controls for GSTP1 genotypes. Frequencies of G allele of GSTP1 were calculated for case group and control group, from the corresponding genotype distribution. The results were compared, and disagreement was resolved by discussion.
Cochrane Review Manager Version 5 (Cochrane Library, UK) was used to calculate the available data from each investigation. The pooled statistic was counted using the fixed effects model, but a random effects model was conducted when the P value of heterogeneity test was <0.1. Results were expressed with odds ratios (ORs) for dichotomous data, and 95% confidence intervals (CIs) were also calculated. P < 0.05 was required for the pooled OR to be statistically significant. I2 was used to test the heterogeneity among the included studies. Sensitivity analysis was also performed according to the source of the controls (population vs. hospital).
| > Results|| |
Fifty studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, reporting the relationship between GSTP1 A/G gene polymorphism and lung cancer susceptibility were recruited into this meta-analysis. The data of our interest were extracted, and the frequencies of G allele of GSTP1 for case group and control group were calculated. The study characteristics of the included studies were presented in [Table 1].
|Table 1: Characteristics of the studies evaluating the effects of glutathione S-transferase P1 A/G gene polymorphism on lung cancer risk|
Click here to view
Association of glutathione S-transferase P1 A/G gene polymorphism with lung cancer risk
In this meta-analysis, we found that GSTP1 G allele was associated with lung cancer risk (OR = 1.08, 95% CI: 1.02–1.14, P = 0.006; [Figure 1] and [Table 2]). Furthermore, the GG genotype was a risk factor for the lung cancer risk (OR = 1.09, 95% CI: 1.00–1.18, P = 0.04; [Figure 2] and [Table 2]). However, AA seemed not to play a protective role against the risk of lung cancer (OR = 0.94, 95% CI: 0.88–1.01, P = 0.09; [Figure 3] and [Table 2]).
|Figure 1: Association between glutathione S-transferase P1 G allele and lung cancer susceptibility|
Click here to view
|Table 2: Meta-analysis of the association of glutathione S-transferase P1 A/G gene polymorphism with risk of lung cancer|
Click here to view
|Figure 2: Association between glutathione S-transferase P1 GG genotype and lung cancer susceptibility|
Click here to view
|Figure 3: Association between glutathione S-transferase P1 AA genotype and lung cancer susceptibility|
Click here to view
In the subgroup analysis according to the ethnicity, this meta-analysis indicated that GSTP1 A/G gene polymorphism was not associated with lung cancer risk in Caucasians [Table 2].
However, in the subgroup analysis for Asian population, GSTP1 G allele was associated with lung cancer risk (OR = 1.15, 95% CI: 1.01–1.30, P = 0.03; [Table 2]). Furthermore, AA seemed to play a protective role against the risk of lung cancer (OR = 0.87, 95% CI: 0.78–0.96, P = 0.008; [Table 2]). However, GG genotype was not associated with lung cancer risk (OR = 1.25, 95% CI: 1.00–1.57, P = 0.05; [Table 2]).
Sensitivity analysis was also performed according to the source of the controls (healthy vs. hospital). The results from this sensitivity analysis of healthy were similar with those from nonsensitivity analysis, and the G allele/GG genotype was associated with the risk of lung cancer for overall populations [Table 3]. However, the results from this sensitivity analysis of hospital indicated that GSTP1 A/G gene polymorphism was not associated with lung cancer risk; and the relationship between G allele/GG genotype and lung cancer risk in overall populations was different from that from nonsensitivity analysis [Table 3].
|Table 3: Meta-analysis of the association of glutathione S-transferase P1 A/G gene polymorphism with risk of lung cancer (sensitivity analysis)|
Click here to view
| > Discussion|| |
In this meta-analysis, the association of GSTP1 G allele/GG genotype with the risk of lung cancer was observed in the overall populations. However, AA genotype was not associated with the onset of lung cancer in overall populations. In the subgroup analysis according to ethnicity, we found that GSTP1 G allele/AA genotype was associated with the risk of lung cancer. However, there was no an association between the GSTP1 A/G gene polymorphism with the risk of lung cancer in Caucasians.
Sensitivity analysis according to the source of the controls (healthy vs. hospital) was performed, and the results for GSTP1 from the sensitivity analysis using the studies using the healthy population as the control group were consistent with the nonsensitivity analysis. However, the result for GSTP1 G allele/GG genotype from the sensitivity analysis using the studies using the hospital nonlung cancer patients as the control group was inconsistent with the nonsensitivity analysis. We speculated that the G allele/GG genotype in hospital nonlung cancer patients might be significant that in healthy populations. However, more studies using should be conducted to explore this speculation.
In our previous meta-analysis, we included 44 reports for the meta-analysis on the relationship between GSTP1 A/G gene polymorphism and lung cancer susceptibility, and reported that GSTP1 G allele is associated with the lung cancer susceptibility. In this meta-analysis, we included fifty reports for meta-analysis and found that G allele/GG genotype might be a significant factor to predict the risk of lung cancer. However, more original studies should be conducted to confirm it in further.
Our results indicated that an association between GSTP1 G allele/GG genotype and lung cancer risk was observed. However, the finding should be regarded cautiously because of many other ingredients, such as limited statistical power, were closely related to affect the results.
| > Conclusion|| |
Our meta-analysis supports that GSTP1 G allele/GG genotype is associated with the risk of lung cancer. However, more association investigations are required to further clarify the association of GSTP1 A/G gene polymorphism with lung cancer risk.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| > References|| |
Sebio Garcia R, Yáñez Brage MI, Giménez Moolhuyzen E, Granger CL, Denehy L. Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: A systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 2016;23:486-97.
Zhang C, Elkahloun AG, Robertson M, Gills JJ, Tsurutani J, Shih JH, et al.
Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance. PLoS One 2011;6:e23849.
Feng X, Zheng BS, Shi JJ, Qian J, He W, Zhou HF. Association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer. Mol Biol Rep 2012;39:10313-23.
Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, et al.
Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997;18:1285-9.
Harris MJ, Coggan M, Langton L, Wilson SR, Board PG. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics 1998;8:27-31.
Jourenkova-Mironova N, Wikman H, Bouchardy C, Voho A, Dayer P, Benhamou S, et al.
Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics 1998;8:495-502.
Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C, et al.
Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 1998;77:516-21.
Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, et al.
Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 1999;9:165-9.
Kihara M, Noda K. Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett 1999;137:53-60.
To-Figueras J, Gené M, Gómez-Catalán J, Piqué E, Borrego N, Carrasco JL, et al.
Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Control 1999;10:65-70.
Kiyohara C, Yamamura KI, Nakanishi Y, Takayama K, Hara N. Polymorphism in GSTM1, GSTT1, and GSTP1 and susceptibility to lung cancer in a Japanese population. Asian Pac J Cancer Prev 2000;1:293-8.
Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, et al.
Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics 2001;11:757-64.
Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett 2002;180:165-71.
Perera FP, Mooney LA, Stampfer M, Phillips DH, Bell DA, Rundle A, et al.
Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis 2002;23:1641-6.
Stücker I, Hirvonen A, de Waziers I, Cabelguenne A, Mitrunen K, Cénée S, et al.
Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis 2002;23:1475-81.
Lin P, Hsueh YM, Ko JL, Liang YF, Tsai KJ, Chen CY. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lung Cancer 2003;40:123-9.
Nazar-Stewart V, Vaughan TL, Stapleton P, Van Loo J, Nicol-Blades B, Eaton DL. A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer 2003;40:247-58.
Reszka E, Wasowicz W, Rydzynski K, Szeszenia-Dabrowska N, Szymczak W. Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition. Neoplasma 2003;50:357-62.
Wang J, Deng Y, Cheng J, Ding J, Tokudome S. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 2003;201:185-93.
Wang Y, Spitz MR, Schabath MB, Ali-Osman F, Mata H, Wu X. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: A case-control study. Lung Cancer 2003;40:25-32.
Chan-Yeung M, Tan-Un KC, Ip MS, Tsang KW, Ho SP, Ho JC, et al.
Lung cancer susceptibility and polymorphisms of glutathione-S-transferase genes in Hong Kong. Lung Cancer 2004;45:155-60.
Schneider J, Bernges U, Philipp M, Woitowitz HJ. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett 2004;208:65-74.
Yang P, Bamlet WR, Ebbert JO, Taylor WR, de Andrade M. Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis 2004;25:1935-44.
Chan EC, Lam SY, Fu KH, Kwong YL. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: Relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Genet Cytogenet 2005;162:10-20.
Cote ML, Kardia SL, Wenzlaff AS, Land SJ, Schwartz AG. Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: A population-based study. Carcinogenesis 2005;26:811-9.
Liang G, Pu Y, Yin L. Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population. Cancer Lett 2005;223:265-74.
Wenzlaff AS, Cote ML, Bock CH, Land SJ, Schwartz AG. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: A population-based study. Carcinogenesis 2005;26:395-401.
Chen HC, Cao YF, Hu WX, Liu XF, Liu QX, Zhang J, et al.
Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China. Dis Markers 2006;22:141-52.
Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis 2006;27:525-32.
Miller DP, Asomaning K, Liu G, Wain JC, Lynch TJ, Neuberg D, et al.
An association between glutathione S-transferase P1 gene polymorphism and younger age at onset of lung carcinoma. Cancer 2006;107:1570-7.
Loft S, Svoboda P, Kasai H, Tjønneland A, Møller P, Sørensen M, et al.
Prospective study of urinary excretion of 7-methylguanine and the risk of lung cancer: Effect modification by mu class glutathione-S-transferases. Int J Cancer 2007;121:1579-84.
Reszka E, Wasowicz W, Gromadzinska J. Antioxidant defense markers modulated by glutathione S-transferase genetic polymorphism: Results of lung cancer case-control study. Genes Nutr 2007;2:287-94.
Sørensen M, Raaschou-Nielsen O, Brasch-Andersen C, Tjønneland A, Overvad K, Autrup H. Interactions between GSTM1, GSTT1 and GSTP1 polymorphisms and smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer 2007;55:137-44.
Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, et al.
Glutathione S-transferase M1, T1 and P1 polymorphisms: Susceptibility and outcome in lung cancer patients. J Exp Ther Oncol 2008;7:73-85.
Yang M, Choi Y, Hwangbo B, Lee JS. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 2007;57:135-42.
Yoon KA, Kim JH, Gil HJ, Hwang H, Hwangbo B, Lee JS. CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women. Lung Cancer 2008;60:40-6.
Honma HN, De Capitani EM, Perroud MW Jr., Barbeiro AS, Toro IF, Costa DB, et al.
Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. Lung Cancer 2008;61:152-62.
Sobti RC, Kaur P, Kaur S, Janmeja AK, Jindal SK, Kishan J, et al.
Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer. Biomarkers 2008;13:282-95.
Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, et al.
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 2008;29:1164-9.
Kumar M, Agarwal SK, Goel SK. Lung cancer risk in north Indian population: Role of genetic polymorphisms and smoking. Mol Cell Biochem 2009;322:73-9.
Gervasini G, San Jose C, Carrillo JA, Benitez J, Cabanillas A. GST polymorphisms interact with dietary factors to modulate lung cancer risk: Study in a high-incidence area. Nutr Cancer 2010;62:750-8.
Lam TK, Rotunno M, Lubin JH, Wacholder S, Consonni D, Pesatori AC, et al.
Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk. Carcinogenesis 2010;31:634-42.
Timofeeva M, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, et al.
Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer. Int J Cancer 2010;127:1547-61.
Vural B, Yakar F, Derin D, Saip P, Yakar A, Demirkan A, et al.
Evaluation of glutathione S-transferase P1 polymorphisms (Ile105Val and Ala114Val) in patients with small cell lung cancer. Genet Test Mol Biomarkers 2012;16:701-6.
Ada AO, Kunak SC, Hancer F, Soydas E, Alpar S, Gulhan M, et al.
Association between GSTM1, GSTT1, and GSTP1 polymorphisms and lung cancer risk in a Turkish population. Mol Biol Rep 2012;39:5985-93.
Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol 2012;7:954-62.
Pliarchopoulou K, Voutsinas G, Papaxoinis G, Florou K, Skondra M, Kostaki K, et al.
Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers. Oncol Lett 2012;3:1301-6.
Dzian A, Halasova E, Matakova T, Kavcova E, Smolar M, Dobrota D, et al.
Lung adenocarcinoma and squamous cell carcinoma in association with genetic polymorphisms of GSTs in Slovak population. Neoplasma 2012;59:160-7.
López-Cima MF, Alvarez-Avellón SM, Pascual T, Fernández-Somoano A, Tardón A. Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias. BMC Cancer 2012;12:433.
Jiang XY, Chang FH, Bai TY, Lv XL, Wang MJ. Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes in the population of Inner Mongolia region. Asian Pac J Cancer Prev 2014;15:5207-14.
Mota P, Silva HC, Soares MJ, Pego A, Loureiro M, Cordeiro CR, et al.
Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility. J Cancer Res Clin Oncol 2015;141:851-60.
Sharma N, Singh A, Singh N, Behera D, Sharma S. Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population. Cancer Epidemiol 2015;39:947-55.
Wang Y, Ren BU, Zhang L, Guo Z. Correlation between metabolic enzyme GSTP1 polymorphisms and susceptibility to lung cancer. Exp Ther Med 2015;10:1521-7.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3]